<DOC>
	<DOCNO>NCT01018134</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety two dose regimen desoximetasone 0.05 % 0.25 % topical spray compare vehicle spray patient moderate severe plaque psoriasis .</brief_summary>
	<brief_title>Desoximetasone Spray 0.05 % , 0.25 % ; Dose Ranging Study</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Desoximetasone</mesh_term>
	<criteria>Have definite clinical diagnosis stable plaque psoriasis involve ≥ 10 % body surface area ( BSA ) . Have combine total lesion severity score ( TLSS ) ≥ 7 target lesion . Have plaque elevation score ≥ 3 ( moderate ) target lesion . The target lesion must area least 5 cm² . Have Physicians Global Assessment ( PGA ) score 3 ( moderate ) 4 ( severe ) baseline overall disease severity . Pregnancy Current diagnosis type psoriasis stable plaque psoriasis psoriasis kind face scalp require active treatment study . History psoriasis unresponsive topical corticosteroid therapy . Dermatological condition may interfere clinical assessment sign symptom psoriasis . Allergy sensitivity corticosteroid history drug hypersensitivity intolerance would compromise safety patient result study . Any condition would place study patient undue risk participation study . Radiation therapy , antineoplastic agent immunosuppressant medication within 4 week prior first dose study drug . Treatment systemic photo antipsoriatic therapy , within 8 week first dose study drug . Treatment within 12 week ( five half life , whichever less ) prior first dose study drug biological therapy psoriasis . Systemic steroid within 4 week first dose study drug . The use inhale intranasal corticosteroid acceptable long usage stable least 2 week prior first dose study drug continue study . Hormonal contraceptives less one complete cycle prior enter study . Topical antipsoriatic agent kind topical corticosteroid reason within 2 week prior first use study drug . Nonprescription antipsoriatic shampoo use scalp allow study . Receipt drug part research study within 30 day prior first dosing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Topical corticosteroid</keyword>
	<keyword>Plaque psoriasis</keyword>
</DOC>